HLB Genex, Inc. Logo

HLB Genex, Inc.

Develops custom enzymes & microbiome solutions for diagnostics, nutrition, and cosmetic markets.

187420 | KO

Overview

Corporate Details

ISIN(s):
KR7187420005
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노1로 65(관평동), 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB Genex, Inc. is a biotechnology company specializing in the development and production of customized enzymes and microbiome-based solutions. The company leverages proprietary R&D platforms, including Microbial Surface Display Technology for high-throughput screening and Recombinant Protein Expression for scalable manufacturing. Its product portfolio consists of industrial special enzymes, such as Lactase, Catalase, and Proteinase K used in molecular diagnostics, and bio-healthcare ingredients like Vitamin K2 and Phytosphingosine for nutritional and cosmetic applications. HLB Genex is also actively engaged in the research and development of microbiome therapeutics by discovering and engineering effector molecules from beneficial microorganisms.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-20 00:00
Capital/Financing Update
주권관련사채권의취득결정
Korean 37.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.8 MB
2025-07-07 00:00
Share Issue/Capital Change
전환가액의조정
Korean 12.7 KB
2025-07-07 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 13.3 KB
2025-06-30 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 18.3 KB
2025-06-26 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.6 KB
2025-06-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-05-21 00:00
M&A Activity
타법인주식및출자증권취득결정
Korean 25.4 KB
2025-05-13 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.8 MB
2025-05-12 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB
2025-05-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-04-30 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 240.1 KB
2025-04-17 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 239.0 KB
2025-04-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-04-15 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 239.0 KB

Automate Your Workflow. Get a real-time feed of all HLB Genex, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB Genex, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB Genex, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

REVVITY, INC. Logo
Provides life sciences & diagnostics technologies to support workflows from discovery to cure.
United States of America
RVTY
REYON PHARMACEUTICAL CO., LTD Logo
Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.
South Korea
102460
Rezolute, Inc. Logo
Developing therapies for rare metabolic diseases, focusing on hyperinsulinism-caused hypoglycemia.
United States of America
RZLT
RHYTHM PHARMACEUTICALS, INC. Logo
Develops precision medicines for rare genetic diseases causing severe obesity and hyperphagia.
United States of America
RYTM
RIGEL PHARMACEUTICALS INC Logo
Develops and commercializes small-molecule drugs for hematology, cancer, and autoimmune diseases.
United States of America
RIGL
Roche Holding AG Logo
A global leader in pharmaceuticals and diagnostics, pioneering personalized healthcare solutions.
Switzerland
RO
ROCKET PHARMACEUTICALS, INC. Logo
Developing LV/AAV gene therapies for rare genetic bone marrow and cardiovascular diseases.
United States of America
RCKT
ROHTO PHARMACEUTICAL CO.,LTD. Logo
Manufactures OTC drugs, skincare, and cosmetics with a focus on eye and dermatological health.
Japan
4527
Roivant Sciences Ltd. Logo
Accelerates medicine and tech development by building agile, focused subsidiary companies.
United States of America
ROIV
RPbio Inc. Logo
A global CDMO specializing in soft capsules, pharmaceuticals, and health functional foods.
South Korea
314140

Talk to a Data Expert

Have a question? We'll get back to you promptly.